Interventions in Structural, Valvular and Congenital Heart Disease
eBook - PDF

Interventions in Structural, Valvular and Congenital Heart Disease

  1. 1,051 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

About this book

At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. But that's changing, thanks to technological advances. Interventions in Structural, Valvular, and Congenital Heart Disease, Second Edition guides you throught the interventional treatment of congenital, valvular, and stru

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Interventions in Structural, Valvular and Congenital Heart Disease by Horst Sievert, Shakeel A. Qureshi, Neil Wilson, Ziyad M. Hijazi, Horst Sievert,Shakeel A. Qureshi,Neil Wilson,Ziyad M. Hijazi in PDF and/or ePUB format, as well as other popular books in Medicine & Cardiology. We have over one million books available in our catalogue for you to explore.

Information

Publisher
CRC Press
Year
2015
Print ISBN
9781482215632
eBook ISBN
9781482215649
Edition
2
Subtopic
Cardiology

Table of contents

  1. Front Cover
  2. Contents
  3. Preface to the Second Edition
  4. Foreword by Dr. Michael Tynan
  5. Foreword by Dr. Martin Leon
  6. Video Contents
  7. Contributors
  8. Chapter 1: How to design and operate a congenital-structural catheterization laboratory
  9. Chapter 2: Operators’ credentials and institutional requirements for congenital and structural heart disease
  10. Chapter 3: Angiography
  11. Chapter 4: Hemodynamics
  12. Chapter 5: Transesophageal 2D and 3D echocardiographic guidance
  13. Chapter 6: Intracardiac echocardiography (ICE)
  14. Chapter 7: Intracardiac echocardiography by Ultra ICE
  15. Chapter 8: Cardiac computed tomography and magnetic resonance imaging in the cath-lab
  16. Chapter 9: Ultrasound guidance
  17. Chapter 10: Percutaneous transfemoral access with big sheaths
  18. Chapter 11: Percutaneous subclavian access
  19. Chapter 12: Access from the common carotid artery
  20. Chapter 13: Transhepatic access
  21. Chapter 14: Transseptal left heart catheterization
  22. Chapter 15: Percutaneous transapical access
  23. Chapter 16: Recanalization methods for postcatheter vessel occlusion
  24. Chapter 17: Transpericardial access
  25. Chapter 18: Surgical access (transapical, transatrial, transaortic, femoral, subclavian)
  26. Chapter 19: Fetal cardiac interventions
  27. Chapter 20: Special considerations in small children and newborns
  28. Chapter 21: Congenital aortic valve stenosis: Background and valvuloplasty in children and adults
  29. Chapter 22: Congenital aortic valve stenosis: Special considerations in neonates
  30. Chapter 23: Aortic stenosis in the elderly: Background, indication for transcatheter treatment, and clinical trial results
  31. Chapter 24: Aortic valve stenosis in the elderly: Balloon aortic valvuloplasty
  32. Chapter 25: Aortic valve stenosis in the elderly: Transcatheter aortic valve implantation—Edwards SAPIEN valve
  33. Chapter 26: Aortic valve stenosis in the elderly: Transcatheter aortic valve implantation—CoreValve
  34. Chapter 27: Aortic valve stenosis in the elderly: Valve-in-valve implantations
  35. Chapter 28: Aortic valve stenosis in the elderly: New percutaneous aortic valves
  36. Chapter 29: Aortic valve stenosis in the elderly: Embolic protection during transcatheter aortic valve implantation
  37. Chapter 30: Pulmonary valve disease: Pulmonary regurgitation—Background, indications for treatment, and clinical trial results
  38. Chapter 31: Pulmonary valve disease: Pulmonary valve stenosis
  39. Chapter 32: Pulmonary valve disease: Pulmonary atresia
  40. Chapter 33: Pulmonary valve disease: Pulmonary valve in cyanotic heart defects with pulmonary oligemia
  41. Chapter 34: Pulmonary valve disease: Transcatheter pulmonary valve implantation with the Melody valve
  42. Chapter 35: Pulmonary valve disease: Transcatheter pulmonary valve implantation with the Edwards sapien valve
  43. Chapter 36: Pulmonary valve disease: New percutaneous pulmonary valves
  44. Chapter 37: Mitral and tricuspid valve stenosis: Percutaneous mitral valvuloplasty
  45. Chapter 38: Mitral and tricuspid valve stenosis: Percutaneous tricuspid valvuloplasty
  46. Chapter 39: Mitral valve insufficiency: Background and indications for treatment
  47. Chapter 40: Mitral valve insufficiency: Mitral valve repair with the MitraClip
  48. Chapter 41: Mitral valve insufficiency: Other new mitral valve repair techniques
  49. Chapter 42: Mitral valve insufficiency: Transcatheter mitral valve implantation
  50. Chapter 43: Tricuspid valve insufficiency: Background and indications for treatment
  51. Chapter 44: Tricuspid valve insufficiency: Melody valve in the tricuspid position
  52. Chapter 45: Tricuspid valve insufficiency: SAPIEN valve in the tricuspid position
  53. Chapter 46: Tricuspid valve insufficiency: Percutaneous caval stent valve implantation for treatment of tricuspid insufficiency
  54. Chapter 47: Tricuspid valve insufficiency: Catheter closure of paravalvular leaks
  55. Chapter 48: Tricuspid valve insufficiency: Catheter closure of perforated sinus of Valsalva
  56. Chapter 49: Atrial septal defect: Background and indications for ASD closure
  57. Chapter 50: Atrial septal defect: Amplatzer- type ASD occluders
  58. Chapter 51: The Figulla-Occlutech device
  59. Chapter 52: The Cera Lifetech device
  60. Chapter 53: ASD-R PFM device
  61. Chapter 54: Cocoon device
  62. Chapter 55: Starway device
  63. Chapter 56: Atrial septal defect: Cardia ASD occluder
  64. Chapter 57: Atrial septal defect: Complications of device closure of ASDs
  65. Chapter 58: Patent foramen ovale closure: Background, indications for closure, and clinical trial results
  66. Chapter 59: Patent foramen ovale closure: Amplatzer-type PFO occluders
  67. Chapter 60: Disorders of the atrial septum: Closure with Helex or Gore septal occluder
  68. Chapter 61: Patent foramen ovale closure: Premere septal occluder
  69. Chapter 62: Patent foramen ovale closure: PFM PFO occluder
  70. Chapter 63: Patent foramen ovale closure: CoherexFlatStent occluder
  71. Chapter 64: Patent foramen ovale closure: SeptRx occluder
  72. Chapter 65: Patent foramen ovale closure: Suture-based PFO closure
  73. Chapter 66: Patent foramen ovale closure: Other new PFO closure techniques
  74. Chapter 67: Patent foramen ovale closure: Complications of device closure of PFOs
  75. Chapter 68: Ventricular septal defect closure: Background, indications for closure, and clinical trial results
  76. Chapter 69: Ventricular septal defect closure: Closure of congenital muscular VSD using the Amplatzer-type muscular VSD occluders
  77. Chapter 70: Ventricular septal defect closure: Closure of perimembranous VSD using Amplatzer-type occluders
  78. Chapter 71: Ventricular septal defect closure: Closure of perimembranous VSD using PFM coil
  79. Chapter 72: Ventricular septal defect closure: Postmyocardial and postsurgery VSDs
  80. Chapter 73: Patent ductus arteriosus (PDA): Background and indications for closure
  81. Chapter 74: Patent ductus arteriosus (PDA): PDA occlusion with the Amplatzer-type devices
  82. Chapter 75: Patent ductus arteriosus (PDA): PDA occlusion with coils
  83. Chapter 76: Patent ductus arteriosus (PDA): Aortopulmonary window
  84. Chapter 77: Systemic arteriovenous fistulas
  85. Chapter 78: Pulmonary arteriovenous fistulas
  86. Chapter 79: Coronary artery fistulas
  87. Chapter 80: Obstructions of the inferior and superior vena cava
  88. Chapter 81: Right ventricular outflow tract obstruction
  89. Chapter 82: Pulmonary artery stenosis
  90. Chapter 83: Pulmonary vein stenosis
  91. Chapter 84: Balloon dilation of aortic coarctation and recoarctation
  92. Chapter 85: Stenting in aortic coarctation and transverse arch/isthmus hypoplasia
  93. Chapter 86: Middle aortic syndrome
  94. Chapter 87: Catheter intervention for hypertrophic obstructive cardiomyopathy
  95. Chapter 88: Hypertrophic obstructive cardiomyopathy: Radio-frequency septal reduction
  96. Chapter 89: Thoracic aortic aneurysms
  97. Chapter 90: A hybrid strategy for the initial management of hypoplastic left heart syndrome: Technical considerations
  98. Chapter 91: Alternative procedures for hypoplastic left heart syndrome as a bridge to transplantation
  99. Chapter 92: Intraoperative VSD device closure
  100. Chapter 93: Intraoperative stent implantation
  101. Chapter 94: Background, indication for LAA closure, and clinical trial results
  102. Chapter 95: Amplatzer cardiac plug
  103. Chapter 96: Watchman device
  104. Chapter 97: Coherex WaveCrest
  105. Chapter 98: Sentre heart
  106. Chapter 99: Other new endocardial and epicardial techniques
  107. Chapter 100: Extracorporeal ventricular assist devices
  108. Chapter 101: Left ventricular partitioning with the cardiokinetics device
  109. Chapter 102: Implantable assist devices for heart failure treatment
  110. Chapter 103: Devices for hemodynamic monitoring
  111. Chapter 104: Neurohumoral remodeling for treatment of hypertension and heart failure
  112. Chapter 105: Catheter retrieval of intracardiac masses
  113. Chapter 106: How to avoid and manage major complications
  114. Back Cover